1445591-99-0

Basic information

• Product Name: (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid
• Synonyms: (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid
• CAS NO: 1445591-99-0
• Molecular Weight: 186.164
• Mol File: 1445591-99-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid(1445591-99-0)
• EPA Substance Registry System: (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid(1445591-99-0)

Safety Data

• Hazardous Substances Data: 1445591-99-0(Hazardous Substances Data)

Upstream product

• 6453-07-2 (+/-)-trans-4-oxo-1,2-cyclopentanedicarboxylic acid bis(methyl ester) 

Downstream Products

• 1042695-87-3 methyl (1R,2R,4S)-2-[5-hexen-1-yl(methyl)carbamoyl]-4-[[2-(4-isopropyl-1,3-thiazol-2-yl)-7-methoxy-8-methyl-4-quinolinyl]oxy]cyclopentanecarboxylate 
• 35079-19-7 trans-(1R,2R)-1,2-Bis(methoxycarbonyl)-4-oxocyclopentane 
• 1042695-88-4 C₃₁H₃₉N₃O₅S 
• 1445653-25-7 C₁₇H₁₇BrN₂O₄ 
• 1445590-82-8 ((7R,8R)-8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonan-7-yl)((R)-3-methylmorpholino)methanone 
• 1445592-02-8 (7R,8R)-methyl 8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonane-7-carboxylate 
• 1445592-01-7 (7R,8R)-7-benzyl 8-methyl 1,4-dioxaspiro[4.4]nonane-7,8-dicarboxylate 
• 1445589-67-2 methyl ((2S)-3-methyl-1-(2-(5-(4-(2-((7S,8S)-8-((R)-3-methylmorpholine-4-carbonyl)-1,4-dioxaspiro[4.4]nonan-7-yl)-1H-imidazol-5-yl)-[1,1‘-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-1-oxobutan-2-yl)carbamate 
• 1445592-00-6 (1R,2R)-1-benzyl 2-methyl 4-oxocyclopentane-1,2-dicarboxylate 

Relevant articles and documents

PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV

Disclosed is a process for the preparation of certain intermediates, e.g. those in the scheme below: which intermediates and processes are useful in the preparation of the macrocyclic HVC inhibitor Simeprevir.